Page last updated: 2024-10-21

abt 702 and Allodynia

abt 702 has been researched along with Allodynia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cowart, M1
Lee, CH2
Gfesser, GA1
Bayburt, EK1
Bhagwat, SS2
Stewart, AO1
Yu, H1
Kohlhaas, KL1
McGaraughty, S1
Wismer, CT2
Mikusa, J2
Zhu, C1
Alexander, KM1
Jarvis, MF2
Kowaluk, EA2
Little, JW1
Ford, A1
Symons-Liguori, AM1
Chen, Z1
Janes, K1
Doyle, T1
Xie, J1
Luongo, L1
Tosh, DK1
Maione, S1
Bannister, K1
Dickenson, AH1
Vanderah, TW1
Porreca, F1
Jacobson, KA1
Salvemini, D1
Zhu, CZ1
Schweitzer, E1
Lynch, JJ1
Jiang, M1
Gomtsyan, A1
McKie, J1
Cox, BF1
Polakowski, J1
Reinhart, G1
Williams, M1

Other Studies

3 other studies available for abt 702 and Allodynia

ArticleYear
Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.
    Bioorganic & medicinal chemistry letters, 2001, Jan-08, Volume: 11, Issue:1

    Topics: Adenosine Kinase; Administration, Oral; Animals; Cell Membrane Permeability; Enzyme Inhibitors; Hype

2001
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.
    Brain : a journal of neurology, 2015, Volume: 138, Issue:Pt 1

    Topics: Adenosine; Animals; Disease Models, Animal; Gene Expression Regulation; Hyperalgesia; Male; Medulla

2015
ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 295, Issue:3

    Topics: Adenosine Kinase; Administration, Oral; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents,

2000